Biopathology of childhood, adolescent and young adult
non-Hodgkin lymphoma

J 2023

Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma

LIM, Megan S, Michelle FOLEY, Lara MUSSOLIN, Reiner SIEBERT, Suzanne Dawn TURNER et. al.

Basic information

Original name

Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma

Authors

LIM, Megan S, Michelle FOLEY, Lara MUSSOLIN, Reiner SIEBERT and Suzanne Dawn TURNER (826 United Kingdom of Great Britain and Northern Ireland, guarantor, belonging to the institution)

Edition

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, OXFORD, ELSEVIER SCI LTD, 2023, 1521-6926

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 2.100 in 2022

RIV identification code

RIV/00216224:14740/23:00133503

Organization unit

Central European Institute of Technology

DOI

http://dx.doi.org/10.1016/j.beha.2023.101447

UT WoS

000974139900001

Keywords in English

Pathobiology; Genetic; Childhood; Adolescent and young adult; Non -Hodgkin lymphoma

Abstract

V originále

Mature non-Hodgkin lymphomas (NHL) in the childhood, adolescent and young adult (CAYA) population are rare and exhibit unique clinical, immunophenotypic and genetic characteristics. Application of large-scale unbiased genomic and proteomic technologies such as gene expression profiling and next generation sequencing (NGS) have led to enhanced understanding of the genetic basis for many lymphomas in adults. However, studies to investigate the pathogenetic events in CAYA population are relatively sparse. Enhanced understanding of the pathobiologic mechanisms involved in non-Hodgkin lymphomas in this unique population will allow for improved recognition of these rare lymphomas. Elucidation of the pathobiologic differences between CAYA and adult lymphomas will also lead to the design of more rational and much needed, less toxic therapies for this population. In this review, we summarize recent insights gained from the proceedings of the recent 7th International CAYA NHL Symposium held in New York City, New York October 20-23, 2022.

Citovat

LIM, Megan S, Michelle FOLEY, Lara MUSSOLIN, Reiner SIEBERT and Suzanne Dawn TURNER. Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. OXFORD: ELSEVIER SCI LTD, 2023, vol. 36, No 1, p. 1-10. ISSN 1521-6926. Available from: https://dx.doi.org/10.1016/j.beha.2023.101447.

@article{2372097,
   author = {Lim, Megan S and Foley, Michelle and Mussolin, Lara and Siebert, Reiner and Turner, Suzanne Dawn},
   article_location = {OXFORD},
   article_number = {1},
   doi = {http://dx.doi.org/10.1016/j.beha.2023.101447},
   keywords = {Pathobiology; Genetic; Childhood; Adolescent and young adult; Non -Hodgkin lymphoma},
   language = {eng},
   issn = {1521-6926},
   journal = {BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY},
   title = {Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma},
   url = {https://www.sciencedirect.com/science/article/pii/S1521692623000087?via%3Dihub},
   volume = {36},
   year = {2023}
}

TY  - JOUR
ID  - 2372097
AU  - Lim, Megan S - Foley, Michelle - Mussolin, Lara - Siebert, Reiner - Turner, Suzanne Dawn
PY  - 2023
TI  - Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma
JF  - BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
VL  - 36
IS  - 1
SP  - 1-10
EP  - 1-10
PB  - ELSEVIER SCI LTD
SN  - 15216926
KW  - Pathobiology
KW  - Genetic
KW  - Childhood
KW  - Adolescent and young adult
KW  - Non -Hodgkin lymphoma
UR  - https://www.sciencedirect.com/science/article/pii/S1521692623000087?via%3Dihub
N2  - Mature non-Hodgkin lymphomas (NHL) in the childhood, adolescent and young adult (CAYA) population are rare and exhibit unique clinical, immunophenotypic and genetic characteristics. Application of large-scale unbiased genomic and proteomic technologies such as gene expression profiling and next generation sequencing (NGS) have led to enhanced understanding of the genetic basis for many lymphomas in adults. However, studies to investigate the pathogenetic events in CAYA population are relatively sparse. Enhanced understanding of the pathobiologic mechanisms involved in non-Hodgkin lymphomas in this unique population will allow for improved recognition of these rare lymphomas. Elucidation of the pathobiologic differences between CAYA and adult lymphomas will also lead to the design of more rational and much needed, less toxic therapies for this population. In this review, we summarize recent insights gained from the proceedings of the recent 7th International CAYA NHL Symposium held in New York City, New York October 20-23, 2022.
ER  -

LIM, Megan S, Michelle FOLEY, Lara MUSSOLIN, Reiner SIEBERT and Suzanne Dawn TURNER. Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma. \textit{BEST PRACTICE \&{}amp; RESEARCH CLINICAL HAEMATOLOGY}. OXFORD: ELSEVIER SCI LTD, 2023, vol.~36, No~1, p.~1-10. ISSN~1521-6926. Available from: https://dx.doi.org/10.1016/j.beha.2023.101447.

Detailed Information on Publication Record